Polyneuron raises CHF 22.5 million in an oversubscribed Series A financing to advance novel therapies for autoimmune diseases. Leading venture capital firm Sofinnova Partners led the Series A financing, together with New Enterprise Associates, which co-led the round  Press Release


In other news